Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Cerebrovascular Diseases(Electronic Edition) ›› 2024, Vol. 18 ›› Issue (04): 393-397. doi: 10.11817/j.issn.1673-9248.2024.04.016

• Review • Previous Articles    

Advances in treatment of atrial fibrillation-related strokes

Fang Li1, Xiwang Dai2, Kai Wang1, Tinghao Guo1, Jianglong Tu1,()   

  1. 1. Department of Neurology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China
    2. Department of Thoracic Surgery, Jiangxi Combined Hospital of Traditional Chinese and Western Medicine, Nanchang 330006, China
  • Received:2023-12-02 Online:2024-08-01 Published:2024-09-06
  • Contact: Jianglong Tu

Abstract:

Non-valvular atrial fibrillation is the most common type of atrial fibrillation in clinical practice, and its prevalence increases with age. In atrial fibrillation, thromboembolic complications are the leading cause of death and disability, with stroke being the most common manifestation. The current therapeutic strategy for atrial fibrillation-associated stroke involves recanalization therapy within the acute temporal window, as well as the treatment of preventing recurrent strokes, with anticoagulant medications being the preferred choice for the treatment of recurrent strokes. Anticoagulants are the first-line treatment for recurrent stroke prevention, however, there is no consensus on the appropriate timing for early anticoagulation in patients with atrial fibrillation who undergo revascularization.

Key words: Stroke, Atrial fibrillation, Intravenous thrombolysis, Endovascular intervention, Anticoagulation

京ICP 备07035254号-20
Copyright © Chinese Journal of Cerebrovascular Diseases(Electronic Edition), All Rights Reserved.
Tel: 01082266456, 15611963912, 15611963911 E-mail: zhnxgbzzbysy@163.com
Powered by Beijing Magtech Co. Ltd